Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2018

Apr 19, 2018

29841_dirs_2018-04-18_784b12c8-fc60-4149-be26-7d1358559dcc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-04-17

Reporting Person: OLEARY DENISE M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-17 Ordinary Shares M 1590 $50.34 Acquired 57698 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-04-17 Stock Option (Right to Buy) $50.34 M 1590 Disposed 2018-04-28 Ordinary Shares (1590) Direct

Footnotes

F1: This balance increased by 548 shares due to exempt transactions such as dividend reinvestment.

F2: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.